Edition:
United States

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

46.29USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$46.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
126,097
52-wk High
$50.00
52-wk Low
$29.59

Select another date:

Tue, May 22 2018

BRIEF-Acceleron Begins Phase 2 Trial Of Pulmonary Arterial Hypertension Treatment

* ACCELERON ANNOUNCES INITIATION OF PULSAR PHASE 2 TRIAL OF SOTATERCEPT IN PULMONARY ARTERIAL HYPERTENSION

BRIEF-Acceleron Reports Q1 Loss Per Share $0.58

* ACCELERON REPORTS FIRST QUARTER 2018 OPERATING AND FINANCIAL RESULTS

BRIEF-Acceleron Receives FDA Fast Track Designation For Ace-083 In Facioscapulohumeral Muscular Dystrophy

* ACCELERON RECEIVES FDA FAST TRACK DESIGNATION FOR ACE-083 IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) Source text for Eikon: Further company coverage:

BRIEF-Acceleron Pharma Q4 Loss Per Share $‍0.62​

* ACCELERON REPORTS FOURTH QUARTER AND FULL YEAR 2017 OPERATING AND FINANCIAL RESULTS

Select another date: